Skip to content
Calculator
Evidence: LowPeptideResearch ChemicalLactic-acid-bacterium bacteriocinsFood-grade antimicrobial peptidesResearch compounds

Plantaricin

A large family of antimicrobial peptides made by Lactobacillus plantarum — natural food preservatives that kill foodborne bacteria, with emerging anticancer research. Research compounds, not drugs

Plantaricins are bacteriocins — small antimicrobial peptides that a bacterium makes to kill its competitors — produced by Lactiplantibacillus plantarum, one of the most common lactic-acid bacteria in fermented foods. Unlike the frog- and venom-derived antimicrobial peptides, plantaricins come from a food-grade microbe and are studied mainly as natural food preservatives. They are small, heat-stable, cationic peptides that permeabilise bacterial membranes, and they are especially good at killing Gram-positive foodborne pathogens such as Listeria monocytogenes. The family is large and genetically organised: L. plantarum carries a cluster of plantaricin genes (the pln locus), and different strains make different plantaricins (plantaricin A, EF, JK, W, BM-1, J, 32 and many more), some of them regulated by a bacterial quorum-sensing signal. Beyond food safety, researchers are now exploring plantaricins for anticancer and immune-modulating effects. Plantaricins are research and food-preservation peptides; they are not approved medicines and have not been given to people as a treatment.

No established human dose Details ↓

Overview

What is it?

Bacteria defend their turf with bacteriocins — antimicrobial peptides they make on the ribosome and secrete to kill competing bacteria — and the plantaricins are the ones made by Lactiplantibacillus plantarum, a lactic-acid bacterium found throughout fermented vegetables, dairy and meats. Because L. plantarum is a food-grade bacterium, plantaricins occupy a different niche from the frog-skin and venom antimicrobial peptides: they are studied first and foremost as natural food preservatives. The family is large and strain-specific, with named members such as plantaricin A, EF, JK, W, BM-1, J and numbered isolates like plantaricin 32, encoded by a cluster of genes known as the plantaricin (pln) locus.

Most plantaricins are small, heat-stable, cationic peptides that act by disrupting the target bacterium's membrane — permeabilising it so that ions, nucleic acids and proteins leak out and the cell dies. A purified plantaricin 32, for example, was an eight-residue peptide that disrupted membrane integrity and also interacted with bacterial DNA. Many plantaricins are regulated by quorum sensing, in which a small peptide pheromone switches on bacteriocin production once enough bacteria are present. Several members come as two-peptide systems whose two chains act together.

Their best-documented use is food biopreservation, especially against Listeria monocytogenes, a dangerous foodborne pathogen. A plantaricin J-containing preparation prevented and reduced Listeria and Salmonella biofilms on stainless steel, silicone and rubber food-contact surfaces, and plantaricin-producing L. plantarum strains added as adjunct cultures suppressed Listeria in fermented milk while improving its texture and flavour. Plantaricin BM-1 has even been used to control the over-souring of yoghurt during storage by gently altering the membrane and metabolism of the yoghurt starter bacterium, and plantaricin 32 combined with chitosan extended the shelf life of pork. These show plantaricins as practical, heat- and pH-stable natural preservatives.

More recently, plantaricins have been explored beyond the food lab. Plantaricin BM-1, given by mouth in a mouse model of colorectal cancer, suppressed tumour growth and shifted the tumour immune environment — increasing cytotoxic CD8+ T cells — and microvesicles from stem cells preconditioned with plantaricin selectively pushed colon-cancer cells toward apoptosis while sparing normal cells. These are early laboratory and animal findings that point to possible anticancer and immunomodulatory roles, not established therapies.

Through all of this, plantaricins remain research and food-preservation peptides. No published study has given a plantaricin to people as a medical treatment, none is approved as a drug anywhere, and material sold online under these names is an unregulated research chemical. Nothing here is a dose or a therapy; this page records what the published science says.

L. plantarum
Source microbe
a food-fermentation lactic-acid bacterium · PMID 41763768
Listeria
Key target
Gram-positive foodborne pathogens · PMID 42155826
0
Human treatment studies
research/food peptides, not given to people · PMID 41983138
Science

Mechanism of Action

Plantaricins are small, heat-stable, cationic bacteriocins made by Lactiplantibacillus plantarum from its pln gene locus, often under quorum-sensing control. They kill mainly Gram-positive bacteria by permeabilising the membrane (some also bind DNA); they are used as food biopreservatives and are being explored for anticancer and immunomodulatory activity.

🧫

Lactic-acid-bacterium bacteriocins

Ribosomally made antimicrobial peptides encoded by the plantaricin (pln) locus of Lactiplantibacillus plantarum, many regulated by quorum sensing (PMIDs 41983138, 41763768).

🦠

Membrane disruption

Permeabilise the bacterial membrane so ions, nucleic acids and proteins leak out, killing Gram-positive foodborne pathogens such as Listeria; some also bind DNA (PMIDs 42155826, 40921163).

🥗

Food biopreservation & emerging roles

Used to suppress pathogens and control fermentation in dairy and meat; early studies report anticancer and immunomodulatory effects of plantaricin BM-1 (PMIDs 41956642, 41983138).

Evidence

Published Research

These are studies of plantaricins read from their PubMed records on November 7, 2026: antibiofilm activity of plantaricin J on food-contact surfaces; plantaricin-producing cultures and plantaricin 32 preserving fermented milk and pork against Listeria and other pathogens; plantaricin BM-1 controlling yoghurt over-souring; and early anticancer work (plantaricin BM-1 in a mouse colorectal-cancer model, and plantaricin-preconditioned stem-cell microvesicles against colon-cancer cells). The evidence is in bacteria, food systems, cells and animals; plantaricins have not been given to people as a treatment.

In Vitro2026

Plantaricin-preconditioned stem-cell microvesicles push colon-cancer cells to apoptosis

Microvesicles from mesenchymal stem cells preconditioned with a low (sub-toxic) dose of plantaricin reduced the viability of HT-29 colorectal-cancer cells and raised apoptosis (shifting apoptosis-regulating genes toward programmed cell death) while showing no significant toxicity to normal HEK-293 cells — an early cell-free anticancer approach in vitro.

PMID: 42886269
In Vitro2026

Plantaricin J prevents and reduces foodborne-pathogen biofilms

Plantaricin J purified from a Lactiplantibacillus plantarum strain was rapidly bactericidal against Listeria monocytogenes and also inhibited Salmonella, and a neutralised plantaricin-J preparation both prevented biofilm formation and reduced established biofilms on stainless steel, silicone and rubber food-contact surfaces, remaining stable across heat and pH — an in-vitro food-safety study.

PMID: 42155826
Animal2026

Plantaricin BM-1 against colorectal cancer in mice

Oral plantaricin BM-1 suppressed tumour growth in a chemically induced mouse model of colorectal cancer, lowered serum TNF-alpha and increased tumour-infiltrating cytotoxic CD8+ T cells; single-cell sequencing and validation indicated it protected CD8+ T cells from apoptosis via the ERK/AP1/Bim pathway — a preclinical anticancer and immunomodulatory result.

PMID: 41983138
In Vitro2026

Plantaricin BM-1 controls yoghurt over-souring

Plantaricin BM-1 altered the cell membrane and metabolism of the yoghurt bacterium Lactobacillus delbrueckii subsp. bulgaricus, reducing its acid production while keeping it alive; multi-omics tied this to changes in fatty-acid metabolism and membrane lipids, and the treatment kept yoghurt from over-souring during storage — a food-technology mechanism study.

PMID: 41956642
In Vitro2026

Plantaricin-producing L. plantarum suppresses Listeria in fermented milk

A plantaricin-producing Lactiplantibacillus plantarum strain used as an adjunct culture reduced Listeria monocytogenes in yoghurt during storage while improving the product's texture, sourness and flavour; the plantaricin was stable across a wide pH range and up to high temperatures — an in-vitro biopreservation study.

PMID: 41763768
In Vitro2025

Novel plantaricin 32 extends pork shelf life with chitosan

Plantaricin 32, an eight-residue bacteriocin purified from a fermented-food L. plantarum, disrupted bacterial membrane permeability and integrity (causing nucleic-acid and protein leakage) and interacted with bacterial DNA; combined with chitosan it inactivated foodborne pathogens in pork and improved its quality during storage — an in-vitro food-preservation study.

PMID: 40921163
Dosing

No Established Human Dose

Plantaricins are bacteriocins studied for food preservation and in the laboratory; none has been given to people as a medical treatment. The work is in bacteria, food systems, cultured cells and animals, at experimental amounts that do not carry over to people. No regulator has approved any plantaricin as a drug, and no published human dose exists, so no amount is printed here.

What this rests on: PMID 42155826, PMID 41983138, PMID 40921163.

Educational information, not medical advice. The doses on this page come from approved labels, published studies and, where no study exists, amounts reported by users. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose. Full medical disclaimer.

For Buyers

What a Buyer Needs to Know

What is sold, how it is mixed, stored and taken, and what is known about its safety, quality and legal status. Each part names its source. Where we have none, it says unknown.

What is sold

Unknown: we hold no label and no published test that says what forms or vial sizes Plantaricin is sold in. A vial's own label is a seller's claim, not a source.

Mixing a vial: a worked example

Unknown: no human dose of Plantaricin has been established (see No Established Human Dose below), so there is no amount to work out. The reconstitution calculator does the arithmetic for any vial, water and dose.

Storage before and after mixing

Unknown: no label or published stability study on file says how to store Plantaricin, before or after mixing. The mixing guide sets out the general rules, with their sources: keep a mixed vial in the fridge, and use it promptly, as the bacteriostatic water label says of any drug dissolved in it. The 28 days often quoted is the limit for an opened multiple-dose vial from a manufacturer, an outer limit set for sterility, not a time a mixed solution has been shown to keep. Nobody has published how long Plantaricin stays intact once mixed.

How it is taken

Unknown: with no established human dose, there is no established way of taking Plantaricin. What the human studies gave and how is set out under No Established Human Dose.

What to expect, and when

How long it stays in the body: a half-life of not established for humans; small heat-stable bacteriocins, stable across pH and heat in food systems. After about five half-lives almost none is left.

When effects appear: unknown; no source on this page gives a time to effect for Plantaricin. Results reported in the studies are under Published Research.

Source: half-life: PMID 42155826.

Side effects, and when to stop or get help

From the Side Effects section: No human adverse-event data exist for plantaricins given as a treatment: no such study has been done; They are produced by a food-grade bacterium (L. plantarum) widely present in fermented foods, but a dietary presence is not the same as a tested therapeutic dose; Some plantaricins and plantaricin-conditioned preparations are cytotoxic to cancer cells in the lab (PMIDs 42886269, 41983138); selectivity for target over healthy cells is an open research question; Material sold online as a 'plantaricin' is an unregulated research chemical of unverified content. Full list and cautions ↓

When to stop or get help: unknown; no label or trial on file sets rules for stopping Plantaricin. Treat a severe or unexpected reaction as a reason to stop and see a doctor.

Source: the Side Effects section below (“Plantaricins are research and food-preservation peptides that have not been given to people as drugs, so there is no human therapeutic safety profile”).

Interactions

Unknown: a PubMed search for human interaction studies of Plantaricin (reviewed 2026-11-07) found none. Unknown is not the same as safe to combine.

Every peptide's record, with its source: the interaction matrix.

Checking what you bought

Unknown: no published independent test of Plantaricin products is in our lab-results database yet, so how products sold under this name measure up is not known.

To read a certificate of analysis, paste it into the COA decoder. Trust & Verification explains what independent testing can and cannot show.

Legal status

US: Research Chemical (Not drugs: Drugs@FDA and the openFDA label endpoint hold no record, and FDA GSRS and ChEMBL hold no approved-drug record for plantaricin peptides (searched November 7, 2026)). Sport: Not on the 2026 List.

Country by country ↓ · Regulatory tracker

Source: this entry's approval status and the WADA Prohibited List, as in Legal Status below.

Safety

Side Effects & Contraindications

Reported Side Effects

Plantaricins are research and food-preservation peptides that have not been given to people as drugs, so there is no human therapeutic safety profile; the points below reflect that status and their biology.

● No human adverse-event data exist for plantaricins given as a treatment: no such study has been done
● They are produced by a food-grade bacterium (L. plantarum) widely present in fermented foods, but a dietary presence is not the same as a tested therapeutic dose
● Some plantaricins and plantaricin-conditioned preparations are cytotoxic to cancer cells in the lab (PMIDs 42886269, 41983138); selectivity for target over healthy cells is an open research question
● Material sold online as a 'plantaricin' is an unregulated research chemical of unverified content

Contraindications & Cautions

Plantaricins have no approved drug use and no label. These points reflect their research status.

● Not medicines: no FDA application or label, and no drug approval anywhere
● No human dosing, interaction, pregnancy or long-term safety data exist for administered plantaricins
● They are lactic-acid-bacterium bacteriocins studied for food preservation and research, not treatments
● Food-preservation use of a bacteriocin is regulated separately from any medical use and is outside this page's scope
Questions

Frequently Asked Questions

?What are plantaricins?

Bacteriocins — antimicrobial peptides — made by the lactic-acid bacterium Lactiplantibacillus plantarum, one of the common microbes in fermented foods. The family is large (plantaricin A, EF, JK, W, BM-1, J, 32 and more), encoded by the pln gene locus (PMID 41983138).

?How do they work?

They are small, heat-stable, cationic peptides that permeabilise bacterial membranes — causing leakage and cell death — and are especially active against Gram-positive foodborne pathogens like Listeria; some also bind DNA (PMIDs 42155826, 40921163).

?What are they used or studied for?

Mainly as natural food preservatives (suppressing pathogens, controlling fermentation), and more recently for anticancer and immunomodulatory activity in cell and animal studies (PMIDs 41763768, 41983138).

?Are they approved or available to buy?

No plantaricin is an approved drug anywhere. They come from a food-grade bacterium and are studied for food preservation and research; any food-additive use is regulated separately from medicine. Material sold online as a plantaricin is an unregulated research chemical. Grey Peptides lists no sellers and recommends no source; this page records the published science.

Bibliography

References

  1. [mechanism] Yaghoubinezhad AR, et al. "Harnessing microvesicles from plantaricin-enhanced stem cells to trigger apoptosis in colon cancer cells." Mol Biol Rep, 2026;53(1). PMID: 42886269.
  2. [mechanism] Pumpuang L, et al. "Antibiofilm Properties of a Plantaricin J-Containing Culture Supernatant from Lactiplantibacillus plantarum AV3: Potential for Inhibiting and Reducing Bacterial Biofilms on Food-Contact Surfaces." J Food Prot, 2026;89(7):100815. PMID: 42155826.
  3. [animal] Zheng X, et al. "Plantaricin BM-1 enhances anti-colorectal cancer effects by inhibiting CD8+ cytotoxic T cell apoptosis via the ERK/AP1/Bim signaling pathway." Front Immunol, 2026;17:1792962. PMID: 41983138.
  4. [mechanism] He Y, et al. "Multi-omics reveal the mechanism of Plantaricin BM-1 in controlling yoghurt post-acidification by affecting the membrane and metabolism of Lactobacillus delbrueckii subsp. bulgaricus." Food Res Int, 2026;233(Pt 2):118897. PMID: 41956642.
  5. [mechanism] Xiao N, et al. "Plantaricin-producing Lactiplantibacillus plantarum NDF28B2 as an adjunct culture enhances fermented Milk texture and suppresses Listeria monocytogenes." Food Res Int, 2026;229:118438. PMID: 41763768.
  6. [mechanism] Zhao D, et al. "A Novel Plantaricin 32 Effectively Inactivates Listeria monocytogenes and Prolongs the Shelf Life of Pork in Conjunction with Chitosan." J Agric Food Chem, 2025;73(37):23310-23320. PMID: 40921163.
  7. [other] Plantaricins are bacteriocins — ribosomally made antimicrobial peptides — produced by the lactic-acid bacterium Lactiplantibacillus plantarum (long known as Lactobacillus plantarum). The plantaricin (pln) gene locus and its regulation were worked out by Nes, Diep and colleagues in the 1990s, and many plantaricin subtypes have since been described. Their production, structure and activities are described in the studies carded on this page (read November 7, 2026).
  8. [other] US FDA, Drugs@FDA and the openFDA label endpoint, searched November 7, 2026: no application and no label record for plantaricin peptides. They are lactic-acid-bacterium bacteriocins studied for food preservation and as research compounds, not approved drugs; FDA GSRS and ChEMBL hold no approved-drug record for them.

Sources & Citations

The six studies carded above were read from their PubMed records on November 7, 2026. The plantaricin family's origin in Lactiplantibacillus plantarum, its organisation in the pln gene locus, its small heat-stable membrane-permeabilising mechanism, its use as a food biopreservative against Listeria and other pathogens, and its emerging anticancer/immunomodulatory activity are from the studies carded here; the pln locus and its regulation were characterised by Nes, Diep and colleagues in the 1990s. The absence of US drug approval or a record from Drugs@FDA, openFDA, FDA GSRS and ChEMBL was checked the same day. Grey Peptides sells nothing and links to no vendor.

Medical Disclaimer: This content is for educational and informational purposes only. It is not medical advice, and nothing here is an instruction to obtain or use any compound. Talk to a licensed clinician about your own situation.

Last reviewed: 2026-11-07